Indo Us Biotech Limited — Results, 26-05-2025: Integrated Filing- Financial

Indo US Bio-Tech Limited has announced a board meeting on 6th June 2025 to review the financial results for the quarter and half-year.

Revenue Performance: The company posted total revenue of Rs. 103.84 Cr in FY25, marking a strong 42.5% YoY growth from Rs. 72.84 Cr. Growth was driven by its core seed cultivation, processing, and trading operations.

Profitability and EPS: Net profit nearly doubled to Rs. 16.27 Cr from Rs. 8.24 Cr, with EPS increasing to Rs. 8.12 from Rs. 4.11. Margin expansion was supported by operational efficiencies and tighter cost management, despite some volatility in production costs.

Operational Costs: Expenses rose to Rs. 87.49 Cr due to higher purchases and production costs tied to scaling up. Employee costs remained stable, pointing to disciplined overhead control. Inventory adjustments helped ease working capital pressures despite overall cost rise.

Key Metrics: EBITDA before tax almost doubled to Rs. 16.53 Cr from Rs. 8.79 Cr. Increased depreciation reflects asset additions for capacity enhancement. The focus on seed production contracts continues to support volume expansion.

Balance Sheet / Cash Flow Health: Total assets increased to Rs. 97.84 Cr, aided by inventory build and fixed asset additions (~Rs. 10.23 Cr in PPE). Borrowings are steady at Rs. 14.83 Cr. Operating cash flow remains robust, though inventory changes slightly tighten liquidity. Capex of ~Rs. 0.86 Cr signals moderate investment for growth.

Management Outlook: The company is prioritizing seed production strengthening and inventory optimization, maintaining financial discipline without fresh borrowings or equity dilution. Its strategic emphasis on farmer contracts and leasehold land supports volume growth.

Final Takeaway: Indo US Bio-Tech demonstrates robust topline and earnings growth fueled by operational efficiencies and controlled costs. Healthy balance sheet and cash flows position it well for sustained expansion in the agriseed space, offering an attractive prospect for investors looking to tap into agritech and seed cultivation sectors.